Skip to content

Is Parent-Child interaction therapy effective on aggression and biological indices in pre-school children with parents who use Tetrahydrocannabinol? A double-blind randomized controlled trial in an Iranian sample

Is Parent-Child interaction therapy effective on aggression and biological indices in pre-school children with parents who use Tetrahydrocannabinol? A double-blind randomized controlled trial in an Iranian sample

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180804001
Enrollment
64
Registered
2018-08-04
Start date
2015-03-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration. Parent&#45

Interventions

child interaction therapy was conducted in two phases of child directed interaction (to improve communication) and parent directed interaction (to practice interactive discipline) in twelve sessions.
and the process of data analysis was carried out by a psychometric analyzer. Allocation concealment was done by the researcher&#44
who was responsible for the randomization.
Child Interaction Therapy (PCIT),control group

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 6 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were: 1) age range of 5-7 years in children; 2) the diagnosis of dependence to Gul with a given dose for at least one of the parents; 3) the diagnosis of aggression syndrome in two clinical domains and evaluation of questionnaires; 4) age range of 20 -45 years for parents; and 5) the ability to read and write.

Exclusion criteria

Exclusion criteria: The exclusion criteria for mothers and children were as follow: 1) lack of natural intelligence with a criterion of less than 70; 2) use of more than three months from psychiatric medications due to the possible effect on the psychological syndrome.

Design outcomes

Primary

MeasureTime frame
Aggression 12 weeks Aggression questionnaire

Secondary

MeasureTime frame
salivary cortisol 12 weeks immunoassay method

Countries

iran

Contacts

Public Contactbijan pirnia

Bijan Center

b.pirnia@usc.ac.ir+9802122081450

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026